Ganga Pharmaceuticals Ltd - 539680 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
This is to certify that the details of securities dematerialized / rematerialized during the quarter ended March 31, 2023 as required under Regulation 74(5) of the SEBI(Depositories and Participants) Regulations, 2018 have been furnished to the Stock Exchange where the shares of the Company are listed. Ganga Pharmaceuticals Ltd - 539680 - Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Or The Year Ended March 31, 2023
Compliance Certificate for the year ended March 31, 2023. Ganga Pharmaceuticals Ltd - 539680 - Closure of Trading Window
Pursuant to Company's Code of Conduct for-prevention, Stock Exchange of Insider Trading, the Trading Window for dealing in the securities of the Company will remain closed for all the Directors, Promoters, Designated Employees and Connected Persons from Saturday, April 01, 2023. The closure is in connection with the declaration of Audited Financial Results of the Company for the half year and financial year ending on March 31, 2023.The Trading Window will open 48 hours after the said financial results are declared to the Stock Exchange. Ganga Pharmaceuticals Ltd - 539680 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2022. Ganga Pharmaceuticals Ltd - 539680 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2022. Ganga Pharmaceuticals Ltd - 539680 - Outcome Of Board Meeting Held On Friday, November 11, 2022
Considered and approved the un- audited Financial Results of the Company for the half year ended on September 30, 2022. Ganga Pharmaceuticals Ltd - 539680 - Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, November 11, 2022
Considered and Approved the un- audited Financial Results of the Company for the half year ended on September 30, 2022 Ganga Pharmaceuticals Ltd - 539680 - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Will Be Held On Friday November 11,2022
Ganga Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 ,inter alia, to consider and approve Meeting of the Board of Directors of the Company will be held on Friday, November 11, 2022 to inter alia, consider and approve the Un-Audited Financial Results of the Company for the half year ended on September 30, 2022. Ganga Pharmaceuticals Ltd - 539680 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2022. Ganga Pharmaceuticals Ltd - 539680 - Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Priti Kothari BhaiyaDesignation :- Company Secretary and Compliance Officer